Literature DB >> 34449270

Health Care Disparities and Access to Video Visits Before and After the COVID-19 Pandemic: Findings from a Patient Survey in Primary Care.

Emily C Webber1,2,3, Brock D McMillen4, Deanna R Willis4.   

Abstract

Background: In 2020, the Centers for Medicare & Medicaid Services reimbursement structure was relaxed to aid in the rapid adoption nationally of telemedicine during the COVID-19 pandemic. Due to limited access to internet service, cellular phone data, and appropriate devices, many patients may be excluded from telemedicine services.
Methods: In this study, we present the findings of a survey of patients at an urban primary care clinic regarding their access to the tools needed for telemedicine before and after the COVID-19 pandemic. Patients provided information about their access to internet services, phone and data plans, and their perceived access to and interest in telemedicine. The survey was conducted in 2019 and then again in September of 2020 after expansion of telemedicine services.
Results: In 2019, 168 patients were surveyed; and in 2020, 99 patients participated. In both surveys, 30% of respondents had limited phone data, no data, or no phone at all. In 2019, the patient responses showed a statistically significant difference in phone plan types between patients with different insurance plans (p < 0.10), with a higher proportion (39%) of patients with Medicaid or Medicaid waiver having a prepaid phone or no phone at all compared with patients with commercial insurance (26%). The overall awareness rate increased from 17% to 43% in the 2020 survey. Conclusions: This survey illustrated that not all patients had access to devices, cellular data, and internet service, which are all needed to conduct telemedicine. In this survey, patients with Medicaid or Medicaid waiver insurance were less likely to have these tools than those with a commercial payor. Finally, patients' access to these telemedicine tools correlated with their interest in using telemedicine visits. Providing equitable telemedicine care requires attention to and mitigation strategies for these gaps in access.

Entities:  

Keywords:  COVID; internet; telemedicine; vulnerable populations

Mesh:

Year:  2021        PMID: 34449270     DOI: 10.1089/tmj.2021.0126

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  5 in total

1.  Disparities in Telehealth Care in Multiple Sclerosis.

Authors:  Ruth Ann Marrie; Leanne Kosowan; Gary Cutter; Robert Fox; Amber Salter
Journal:  Neurol Clin Pract       Date:  2022-06

2.  Examining telehealth use among primary care patients, providers, and clinics during the COVID-19 pandemic.

Authors:  Claudia Der-Martirosian; Karen Chu; W Neil Steers; Tamar Wyte-Lake; Michelle D Balut; Aram Dobalian; Leonie Heyworth; Neil M Paige; Lucinda Leung
Journal:  BMC Prim Care       Date:  2022-06-18

3.  Telemedicine for outpatient palliative care during COVID-19 pandemics: a longitudinal study.

Authors:  Augusto Caraceni; Chiara Pellegrini; Morena Shkodra; Ernesto Zecca; Paola Bracchi; Silvia Lo Dico; Mariangela Caputo; Simonetta Zappata; Emanuela Zito; Cinzia Brunelli
Journal:  BMJ Support Palliat Care       Date:  2022-06-16       Impact factor: 4.633

4.  Inpatient Telehealth Experience of Patients With Limited English Proficiency: Cross-sectional Survey and Semistructured Interview Study.

Authors:  Lily Payvandi; Chase Parsons; Fabienne C Bourgeois; Jonathan D Hron
Journal:  JMIR Form Res       Date:  2022-04-19

5.  The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future.

Authors:  Stefano Omboni; Raj S Padwal; Tourkiah Alessa; Béla Benczúr; Beverly B Green; Ilona Hubbard; Kazuomi Kario; Nadia A Khan; Alexandra Konradi; Alexander G Logan; Yuan Lu; Maurice Mars; Richard J McManus; Sarah Melville; Claas L Neumann; Gianfranco Parati; Nicolas F Renna; Philippe Ryvlin; Hugo Saner; Aletta E Schutte; Jiguang Wang
Journal:  Connect Health       Date:  2022-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.